Minimal Residual Disease (MRD) As A Predictive Biomarker/Endpoint for Novel Drug Development | NeoGenomics Laboratories

Publication date

Thu, 04/14/2022 - 12:00

Year

Subtitle

AACR 2022

File

MRD_Poster_AACR%202022-NPJ_final.pdf (1.25 MB)

Division